top of page


Press releases


Nov 4, 2024
Sachi's Nanoligomer treatments and nearly 600 patient-based brain Organoids fly on NASA's Space X CRS 31 Mission
Sachi Bio plans to utilize brain organoids in microgravity, which is the state of apparent weightlessness experienced during free fall or...


Sep 6, 2024
Sachi Bio’s New Treatment Featured by Multiple Media Outlets: A “game-changing tool” in fight against Alzheimer’s, Dementia, and Aging
KEYWORDS: Alzheimer’s, aging, dementia, treatment, Nanoligomer Read more at: Denver Post Colorado State University Press release DENVER -...


Sep 2, 2024
Age-reversing effects of Sachi's Drug Molecule published in the Journal of Neuroinflammation
As the brain gets older or in conditions like Alzheimer’s, inflammation becomes a major problem that damages brain cells, leading to...


Apr 15, 2024
Sachi Bio wins NASA Phase IIE and III contracts to Develop Neuroprotective Countermeasures for Long-term Space travel
Sachi Bio won Phase IIE and Phase III contracts from the NASA Human Research Program to continue advancement of the Neurotherapeutic...

Mar 31, 2024
Investigational New Drug (IND)-enabling Studies for Sachi Bio's lead molecule
Sachi Bio's lead program NI112 shows excellent Safety-Toxicity, brain-delivery, and biodistribution profile in Investigational New Drug...


Jan 31, 2024
Sachi Bio lead programs to support NASA Missions & counter debilitating diseases on Earth
"Sachi Bio has successfully advanced it's lead program towards translation for a range of neurodegenerative diseases, as well as a...


Aug 31, 2023
Sachi Bio presents at ISSR&D Conference as it aims to become the first company in the world to test RNA Therapeutics in Space
Sachi Bio presented data on human brain organoids and their treatment with Nanoligomers, to the space community in the ISSR&D conference...


Subscribe to Our Newsletter
bottom of page